Liriodenine exhibits significant biological activity, making it valuable in pharmaceutical research. It shows promising antitumor properties by inhibiting the growth of various cancer cell lines through interference with cell cycle progression and induction of apoptosis. Its antimicrobial effects are effective against certain bacteria and fungi, suggesting potential use in developing new anti-infective agents. Additionally, liriodenine demonstrates anti-inflammatory and antioxidant activities, which may contribute to its therapeutic potential in treating chronic inflammatory conditions. Due to its ability to interact with DNA and enzymes involved in cellular replication, it is also studied as a lead compound for designing novel cytotoxic agents in oncology.